Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

CAS Medical Systems CEO: Following the resignation of Andrew E. Kersey as president, CEO and board member, the maker of non-invasive patient-monitoring devices appoints former Wright Medical Group CEO Thomas M. Patton to the same positions Aug. 27. Patton, who was most recently an advisor to private equity group Ferrer Freeman & Co. and CEO of hematology diagnostics start-up QDx, will help CAS Medical Systems commercialize its Fore-Sight Absolute Oximetry technology

You may also be interested in...



Syneron Expects Candela Acquisition To Expand Aesthetics Marketing Reach

Syneron Medical aims to extend its global sales reach and obtain new dermatologist and cosmetic surgeon customers through its $65 million purchase of fellow aesthetic device maker Candela

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029349

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel